• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRAME表达作为横纹肌样黑色素瘤有用的免疫组化标志物

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma.

作者信息

Glutsch Valerie, Wobser Marion, Schilling Bastian, Gesierich Anja, Goebeler Matthias, Kneitz Hermann

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, 97080 Würzburg, Germany.

出版信息

Dermatopathology (Basel). 2022 May 2;9(2):148-157. doi: 10.3390/dermatopathology9020019.

DOI:10.3390/dermatopathology9020019
PMID:35645230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9149841/
Abstract

BACKGROUND

Rhabdoid melanoma is a rare variant of malignant melanoma with characteristic cytomorphologic features. Due to the potential loss of conventional melanocytic markers, histopathologic diagnosis is often challenging. We hypothesize that immunostaining for (PRAME) might have the potential to uncover the melanocytic origin of these dedifferentiated tumors.

METHODS

Four cases of rhabdoid primary melanomas were assessed by immunohistochemistry for expression of PRAME and conventional melanocytic markers. Immunohistochemical expression patterns were analyzed in the rhabdoid primaries and, if available, associated metastases.

RESULTS

All four cases of rhabdoid primary melanomas showed a strong nuclear positivity for PRAME, while the expression of conventional melanocytic markers S100, MART-1, SOX-10 and HMB-45 was variable between the analyzed cases.

CONCLUSIONS

In summary, we report four cases of rhabdoid primary melanoma with high to intermediate expression of PRAME despite the partial and variable loss of other melanocytic markers. Hence, PRAME might facilitate the recognition of this highly aggressive entity to avoid misdiagnosis due to histopathologic pitfalls.

摘要

背景

横纹肌样黑色素瘤是恶性黑色素瘤的一种罕见变体,具有特征性的细胞形态学特征。由于传统黑素细胞标志物可能缺失,组织病理学诊断往往具有挑战性。我们推测,PRAME免疫染色可能有潜力揭示这些去分化肿瘤的黑素细胞起源。

方法

通过免疫组织化学评估4例横纹肌样原发性黑色素瘤中PRAME和传统黑素细胞标志物的表达。分析横纹肌样原发性肿瘤以及(若有)相关转移灶中的免疫组织化学表达模式。

结果

4例横纹肌样原发性黑色素瘤均显示PRAME强核阳性,而分析的病例中传统黑素细胞标志物S100、MART-1、SOX-10和HMB-45的表达各不相同。

结论

总之,我们报告了4例横纹肌样原发性黑色素瘤,尽管其他黑素细胞标志物部分缺失且存在差异,但PRAME表达为高到中度。因此,PRAME可能有助于识别这种高度侵袭性的实体,避免因组织病理学陷阱导致的误诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/8b8f5962cf9e/dermatopathology-09-00019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/2c3e37d51b9c/dermatopathology-09-00019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/06ccd239f4f0/dermatopathology-09-00019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/8b8f5962cf9e/dermatopathology-09-00019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/2c3e37d51b9c/dermatopathology-09-00019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/06ccd239f4f0/dermatopathology-09-00019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c3/9149841/8b8f5962cf9e/dermatopathology-09-00019-g005.jpg

相似文献

1
PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma.PRAME表达作为横纹肌样黑色素瘤有用的免疫组化标志物
Dermatopathology (Basel). 2022 May 2;9(2):148-157. doi: 10.3390/dermatopathology9020019.
2
PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics.PRAME是黑色素细胞肿瘤及其组织学相似病变鉴别诊断的有用标志物。
Histopathology. 2023 Jan;82(2):285-295. doi: 10.1111/his.14814. Epub 2022 Oct 13.
3
Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.一系列黑素细胞肿瘤中黑色素瘤免疫染色中优先表达的抗原
Am J Dermatopathol. 2021 Nov 1;43(11):794-800. doi: 10.1097/DAD.0000000000001885.
4
PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.具有中间组织病理学或 Spitz 样特征的黑色素细胞增生中 PRAME 的表达。
J Cutan Pathol. 2020 Dec;47(12):1123-1131. doi: 10.1111/cup.13818. Epub 2020 Sep 10.
5
PRAME Expression in Melanocytic Tumors.黑色素细胞肿瘤中的 PRAME 表达。
Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134.
6
PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation.PRAME 在具有黑色素细胞分化的具有挑战性的皮肤黑色素细胞肿瘤和软组织肿瘤中的表达。
Am J Dermatopathol. 2022 Jun 1;44(6):404-410. doi: 10.1097/DAD.0000000000002128. Epub 2022 Jan 5.
7
The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.PRAME免疫组化在具有挑战性的黑素细胞肿瘤评估中的应用
J Cutan Pathol. 2021 Sep;48(9):1115-1123. doi: 10.1111/cup.14000. Epub 2021 Mar 15.
8
Performance of PRAME immunohistochemistry compared with that of c-Kit, c-Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors.PRAME 免疫组化与 c-Kit、c-Myc 或 cyclin D1 用于诊断肢端黑色素瘤的比较。
Pathol Int. 2023 Jan;73(1):27-36. doi: 10.1111/pin.13292. Epub 2022 Dec 5.
9
PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions.PRAME 免疫组织化学作为评估黑色素细胞病变的辅助检测手段。
Surg Pathol Clin. 2021 Jun;14(2):165-175. doi: 10.1016/j.path.2021.01.001. Epub 2021 Apr 28.
10
Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail Apparatus.免疫组织化学在甲黑素细胞病变鉴别诊断中用于黑色素瘤优先表达抗原的研究。
Am J Dermatopathol. 2022 Jul 1;44(7):488-492. doi: 10.1097/DAD.0000000000002143. Epub 2022 Feb 2.

引用本文的文献

1
Primary Cutaneous Rhabdomyosarcomatous Melanomas-A Report of Two Cases and Literature Review.原发性皮肤横纹肌肉瘤样黑色素瘤——两例报告及文献复习
Diagnostics (Basel). 2025 May 28;15(11):1357. doi: 10.3390/diagnostics15111357.
2
Diffuse PRAME Expression in Transdifferentiated Melanomas.弥漫性PRAME在转分化黑色素瘤中的表达
J Cutan Pathol. 2025 Apr;52(4):269-271. doi: 10.1111/cup.14769. Epub 2024 Dec 3.
3
Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment.

本文引用的文献

1
PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer Analysis.基于泛癌分析,PRAME是一种潜在的致癌生物标志物,与患者预后和肿瘤免疫相关。
Ann Clin Lab Sci. 2022 Mar;52(2):185-195.
2
Cutaneous Involvement in Plasma Cell Myeloma.浆细胞骨髓瘤的皮肤累及。
Am J Clin Pathol. 2021 Jan 4;155(1):106-116. doi: 10.1093/ajcp/aqaa122.
3
Case of primary hypomelanotic rhabdoid melanoma on the forehead.前额原发性色素减退性横纹肌样黑色素瘤病例。
原发性未分化/去分化皮肤黑色素瘤——组织学、免疫组织化学和分子特征的综述,重点是预后和治疗。
Int J Mol Sci. 2023 Jun 10;24(12):9985. doi: 10.3390/ijms24129985.
J Dermatol. 2019 Aug;46(8):e278-e279. doi: 10.1111/1346-8138.14838. Epub 2019 Mar 7.
4
PRAME Expression in Melanocytic Tumors.黑色素细胞肿瘤中的 PRAME 表达。
Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134.
5
Primary amelanotic rhabdoid melanoma of the forehead.
Br J Dermatol. 2016 May;174(5):1156-8. doi: 10.1111/bjd.14382. Epub 2016 Feb 4.
6
Primary Amelanotic Rhabdoid Melanoma: A Case Report with Review of the Literature.原发性无黑色素性横纹肌样黑色素瘤:一例报告并文献复习
Case Rep Dermatol. 2015 Oct 10;7(3):292-7. doi: 10.1159/000441347. eCollection 2015 Sep-Dec.
7
Rhabdoid melanoma: a case report with review of the literature.横纹肌样黑色素瘤:一例病例报告并文献复习
Int J Clin Exp Pathol. 2014 Jan 15;7(2):840-3. eCollection 2014.
8
Tissue interactions in neural crest cell development and disease.神经嵴细胞发育和疾病中的组织相互作用。
Science. 2013 Aug 23;341(6148):860-3. doi: 10.1126/science.1230717.
9
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.周围神经鞘瘤的病理学:诊断概述及部分诊断问题的更新。
Acta Neuropathol. 2012 Mar;123(3):295-319. doi: 10.1007/s00401-012-0954-z. Epub 2012 Feb 12.
10
Primary malignant rhabdoid melanoma.原发性恶性横纹肌样黑色素瘤。
Ann Dermatol. 2011 Oct;23(Suppl 2):S155-9. doi: 10.5021/ad.2011.23.S2.S155. Epub 2011 Oct 31.